OKYO Pharma Limited (OKYO)
Last updated: 2026-10-21 16:04:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
OKYO Pharma Limited (OKYO) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.62, with a market capitalization of $73.47M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.26 to $3.20. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$73.47M | |
$1.52 | |
$7.00 | |
$0.81 | |
$1.37 | |
110.20K | |
70.87K | |
-- | |
$3.20 | |
$1.26 | |
-- | |
-- |
OKYO Pharma Limited (OKYO) Stock Price Today
OKYO Pharma Limited (OKYO) is currently trading at $1.62 as of 2026-10-21 16:02:00, up 17.88% ($0.24) from the previous close of $1.37
During today's regular trading session, OKYO has traded between $0.81 and $7.00, with a trading volume of 110.20K shares. The current price is near the lower end of today's range.
OKYO Pharma Limited (OKYO) 7-Day Stock Price Change
Over the past seven days, OKYO Pharma Limited (OKYO) moved from $1.44 to $1.62, representing a gain of 12.15% ($0.18).
The stock traded between $1.37 and $1.62 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 37.01 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
OKYO 52-Week Price Position
Position in Range: 18.1%
OKYO is currently trading at $1.62, placing it 18.1% of the way from its 52-week low of $1.26 to its 52-week high of $3.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is OKYO Pharma Limited (OKYO)?
OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.
OKYO Pharma Limited Information
| Employees | 5 |
| Exchange | NASDAQ |
| Company Website |
How to Buy OKYO Pharma Limited (OKYO) Stock on MEXC
Eligible investors can buy real shares of OKYO Pharma Limited (OKYO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is OKYO Pharma Limited (OKYO) stock price today?
2.Is OKYO stock going up or down today?
3.What is OKYO pre-market price?
4.What is OKYO after-hours price?
5.Is OKYO stock trading now?
6.Where does OKYO sit relative to its 52-week high and low?
7.What sector is OKYO Pharma Limited in?
8.What is OKYO Pharma Limited's market capitalization and where is it listed?
9.How is OKYO valued in terms of P/E ratio and EPS?
10.Does OKYO Pharma Limited pay a dividend?
Explore More US Stocks
Search Stocks
OKYO Stock Calculator
Estimate the value between OKYO shares and USD.
OKYO Shares to USD
1.00 OKYO shares = 1.615 USD
Calculations are estimates based on the latest available price and are for reference only.



